ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1998
The purpose of this study was to assess the difference in disease-free survival between post-menopausal women with hormone receptor-positive early breast cancer who switched from tamoxifen to anastrozole and those who continued on tamoxifen.
Epistemonikos ID: 37dcb787b11c0e0e82547350063906975778c097
First added on: Apr 22, 2015